DANA HEMSTREET: Open Payments
NPI 1679845531 · TUSCALOOSA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,605 in 119 payments from 21 companies in 2025. Trend: 2023 $2,338 · 2024 $2,510 · 2025 $2,605
Food & beverage: $1,405Long term medical supply or device loan: $1,200
| Company | Payments | Amount |
|---|---|---|
| AngioDynamics, Inc. | 1 | $1,200 |
| PFIZER INC. | 14 | $240 |
| Becton, Dickinson and Company | 3 | $181 |
| Novartis Pharmaceuticals Corporation | 61 | $170 |
| Bard Peripheral Vascular, Inc. | 3 | $139 |
| Novo Nordisk Inc | 8 | $134 |
| Actelion Pharmaceuticals US, Inc. | 5 | $99 |
| United Therapeutics Corporation | 3 | $94 |
| Merck Sharp & Dohme LLC | 4 | $59 |
| Amgen Inc. | 3 | $46 |
Products named: VenaCure 1470 Pro, VYNDAQEL, RotarexS 6 F x 135 cm, LEQVIO, Wegovy, Venovo, Tyvaso, UPTRAVI.
Industry payments across AL — which companies pay providers there.
